company background image
FRE logo

Firebrick Pharma ASX:FRE Stock Report

Last Price

AU$0.07

Market Cap

AU$12.6m

7D

14.8%

1Y

-57.6%

Updated

26 May, 2024

Data

Company Financials

FRE Stock Overview

Engages in the development and partnering of broad-spectrum antimicrobial spray for the treatment of common cold under the Nasodine name in Australia.

FRE fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Firebrick Pharma Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Firebrick Pharma
Historical stock prices
Current Share PriceAU$0.07
52 Week HighAU$0.36
52 Week LowAU$0.036
Beta1.67
1 Month Change12.90%
3 Month Change40.00%
1 Year Change-57.58%
3 Year Changen/a
5 Year Changen/a
Change since IPO-86.79%

Recent News & Updates

Here's Why We're Watching Firebrick Pharma's (ASX:FRE) Cash Burn Situation

Aug 14
Here's Why We're Watching Firebrick Pharma's (ASX:FRE) Cash Burn Situation

Recent updates

Here's Why We're Watching Firebrick Pharma's (ASX:FRE) Cash Burn Situation

Aug 14
Here's Why We're Watching Firebrick Pharma's (ASX:FRE) Cash Burn Situation

We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

May 02
We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

Dec 14
We Think Firebrick Pharma (ASX:FRE) Needs To Drive Business Growth Carefully

Companies Like Firebrick Pharma (ASX:FRE) Are In A Position To Invest In Growth

Aug 30
Companies Like Firebrick Pharma (ASX:FRE) Are In A Position To Invest In Growth

Shareholder Returns

FREAU PharmaceuticalsAU Market
7D14.8%0.2%-1.1%
1Y-57.6%56.2%8.7%

Return vs Industry: FRE underperformed the Australian Pharmaceuticals industry which returned 56.2% over the past year.

Return vs Market: FRE underperformed the Australian Market which returned 8.7% over the past year.

Price Volatility

Is FRE's price volatile compared to industry and market?
FRE volatility
FRE Average Weekly Movement19.1%
Pharmaceuticals Industry Average Movement9.9%
Market Average Movement8.9%
10% most volatile stocks in AU Market17.3%
10% least volatile stocks in AU Market3.3%

Stable Share Price: FRE's share price has been volatile over the past 3 months.

Volatility Over Time: FRE's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2012n/aPeter Molloywww.firebrickpharma.com

Firebrick Pharma Limited engages in the development and partnering of broad-spectrum antimicrobial spray for the treatment of common cold under the Nasodine name in Australia. The company was incorporated in 2012 and is based in Melbourne, Australia.

Firebrick Pharma Limited Fundamentals Summary

How do Firebrick Pharma's earnings and revenue compare to its market cap?
FRE fundamental statistics
Market capAU$12.55m
Earnings (TTM)-AU$4.57m
Revenue (TTM)AU$1.82m

6.9x

P/S Ratio

-2.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
FRE income statement (TTM)
RevenueAU$1.82m
Cost of RevenueAU$0
Gross ProfitAU$1.82m
Other ExpensesAU$6.39m
Earnings-AU$4.57m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.025
Gross Margin100.00%
Net Profit Margin-251.57%
Debt/Equity Ratio0%

How did FRE perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.